Teva Pharmaceuticals
TEVA
TEVA
648 hedge funds and large institutions have $19.5B invested in Teva Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 239 increasing their positions, 236 reducing their positions, and 88 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less funds holding
Funds holding: 686 → 648 (-38)
34% less first-time investments, than exits
New positions opened: 58 | Existing positions closed: 88
38% less call options, than puts
Call options by funds: $406M | Put options by funds: $660M
Holders
648
Holding in Top 10
21
Calls
$406M
Puts
$660M
Top Buyers
| 1 | +$287M | |
| 2 | +$207M | |
| 3 | +$207M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$189M |
| 5 |
TIM
Thornburg Investment Management
Santa Fe,
New Mexico
|
+$133M |
Top Sellers
| 1 | -$155M | |
| 2 | -$139M | |
| 3 | -$132M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$108M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$81.6M |